Erythromycin Ethyl Succinate-13C,D3

Erythromycin Ethyl Succinate-13C,D3

VS CAT No VS-E006D06
CAS No NA
Mol.F. C4213CH72D3NO16
Mol.Wt. 866.1
Inv. Status Custom Synthesis

Chemical Name: Ethyl ((2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyl-4-(methyl(methyl-13C-d3)amino)tetrahydro-2H-pyran-3-yl) succinate

Shipping Temperature: Ambient

Country of Origin: India

Smiles: O=C(CCC(OCC)=O)O[C@H]([C@H](C1)N([13C]([2H])([2H])[2H])C)[C@@H](O[C@@H]1C)O[C@@H]([C@](O)(C[C@H](C([C@@H]([C@H]2O)C)=O)C)C)[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)2C)CC)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC)C

Erythromycin Ethyl Succinate-13C,D3 is chemically Ethyl ((2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyl-4-(methyl(methyl-13C-d3)amino)tetrahydro-2H-pyran-3-yl) succinate. Erythromycin Ethyl Succinate-13C,D3 is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin Ethyl Succinate-13C,D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.